With more than $270 billion in commitments to date, a new wave of pharmaceutical manufacturing is slated to hit the US. At least, that’s what the industry is trying to project. Behind the ...

Big pharma, big investments If Trump’s aim was to at least attract investment into the US pharmaceutical manufacturing sector, then the President can tick that box. Drugmakers have poured ...

For the pharma industry, the question becomes: How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Similarly, Aurobindo Pharma is recalling 13,605 bottles of Clorazepate Dipotassium Tablets (3.75 mg and 7.5 mg) from the US market. Clorazepate Dipotassium Tablets are used to treat anxiety.

SEOUL, South Korea, June 19, 2025 /PRNewswire/ -- LOTTE BIOLOGICS announced on June 19, 2025 that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a ...

Indian pharma stocks took a beating on Tuesday, 17 June, after US President Donald Trump said tariffs on pharmaceutical imports are coming “very soon." His comments sent shockwaves across the ...

The acquisition boosts Torrent Pharma’s rank from 7th to 5th place, increasing its market share from 3.6% to 4.6%, according to data gathered by TOI from market intelligence firm Pharmarack.

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant.

LOTTE BIOLOGICS announced on June 19, 2025 that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, ...